Balaji Kavety
Associate Director, Corporate FP&A, R&D Finance at ZIOPHARM Oncology Inc. - Boston, MA, US
Balaji Kavety's Colleagues at ZIOPHARM Oncology Inc.
Balaji Kavety's Contact Details
HQ
617-259-1970
617-259-1970
Location
Mansfield,Massachusetts,United States
Mansfield,Massachusetts,United States
Company
ZIOPHARM Oncology Inc.
ZIOPHARM Oncology Inc.
Balaji Kavety's Company Details
Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.
Frequently Asked Questions about Balaji Kavety
Balaji Kavety currently works for Ziopharm Oncology.
Balaji Kavety's role at Ziopharm Oncology is Associate Director, Corporate FP&A, R&D Finance.
Balaji Kavety's email address is ***@ziopharm.com. To view Balaji Kavety's full email address, please signup to ConnectPlex.
Balaji Kavety works in the Research industry.
Balaji Kavety's colleagues at ZIOPHARM Oncology Inc. are Quinn Houlahan, Andrew Davis, Kamal Chadha, Grace Chen, David Torres, Ellee de Groot, Konrad Gabrusiewicz and others.
Balaji Kavety's phone number is 617-259-1970